Initiation of coverage | BIOCORP | Keep Me Connected!
Biocorp a pharmaceutical devices specialist. Created in 2004, the group manufactures traditional medical devices (such as stoppers, droppers etc.) for big players such as Sanofi and has also developed a range of innovative products to improve liquid transfer or to protect patients from needles during injections. Biocorp has signed several agreements to develop and manufacture new devices which should generate about EUR5m/year in sales starting in 2021.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.